Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 50
Item hits:
Issue DateTitleAuthor(s)
22-Dec-2014LARP1 post-transcriptionally regulates mTOR and contributes to cancer progressionMura, M; Hopkins, TG; Michael, T; Abd-Latip, N; Weir, J, et al
18-Mar-2014A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2 '-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancerGlasspool, RM; Brown, R; Gore, ME; Rustin, GJS; McNeish, IA, et al
4-Oct-2016The GAS6-AXL signaling network is a mesenchymal (Mes) molecular subtype-specific therapeutic target for ovarian cancerAntony, J; Tan, TZ; Kelly, Z; Low, J; Choolani, M, et al
1-Jun-2015The next steps in improving the outcomes of advanced ovarian cancerOpenshaw, MR; Fotopoulou, C; Blagden, S; Gabra, H
6-Nov-2016Response to sunitinib (Sutent) in chemotherapy refractory clear cell ovarian cancerAlifrangis, C; Thornton, A; Fotopoulou, C; Krell, J; Gabra, H
16-May-2017Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) ConsortiumRuscito, I; Castillo-Tong, DC; Vergote, I; Ignat, I; Stanske, M, et al
18-Feb-2018Dynamics of the intratumoral immune response during progression of high-grade serous ovarian cancerStanske, M; Wienert, S; Castillo-Tong, DC; Kreuzinger, C; Vergote, I, et al
28-Feb-2017Adiposity and cancer at all anatomic sites: an umbrella review of the literatureKyrgiou, M; Kalliala, I; Markozannes, G; Gunter, M; Paraskevaidis, E, et al
20-May-2015Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignanciesBlagden, SP; Rizzuto, I; Stavraka, C; O'Shea, D; Suppiah, P, et al
20-May-2015A first in human Phase I/II study of NUC-1031 in patients with advanced gynecological cancersBlagden, SP; Rizzuto, I; Stavraka, C; O'Shea, D; Suppiah, P, et al